The kinase domain of mitochondrial PINK1 faces the cytoplasm

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 33, 2008, Pages 12022-12027

  Zhou, Chun ^a   Huang, Yong ^a   Shao, Yufang ^a   May, Jessica ^a   Prou, Delphine ^a   Perier, Celine ^a   Dauer, William ^a   Schon, Eric A ^a   Przedborski, Serge ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

Mitochondria; Parkin; Parkinson's disease; Topology

Indexed keywords

BIOLOGICAL MARKER; MITOCHONDRIAL PROTEIN; PHOSPHOTRANSFERASE; PINK1 ENZYME; PROTEIN KINASE; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MITOCHONDRIAL MEMBRANE; MOLECULAR CLONING; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; CYTOPLASM; HUMANS; MICE; MICE, KNOCKOUT; MITOCHONDRIA; MITOCHONDRIAL MEMBRANES; PROTEIN KINASES;

EID: 50149121528     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0802814105     Document Type: Article

References (40)

1. Vila M, Przedborski S (2004) Genetic clues to the pathogenesis of Parkinson's disease. Nat Med 10 Suppl:S58-S62.
2. Klein C, Lohmann-Hedrich K (2007) Impact of recent genetic findings in Parkinson's disease. Curr Opin Neurol 20:453-464.
3. Valente EM, et al. (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304:1158-1160.
4. Deng H, Jankovic J, Guo Y, Xie W, Le W (2005) Small interfering RNA targeting the PINK1 induces apoptosis in dopaminergic cells SH-SY5Y. Biochem Biophys ResCommun 337:1133-1138.
5. Petit A, et al. (2005) Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations. J Biol Chem 280:34025-34032.
6. Silvestri L, et al. (2005) Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism. Hum Mol Genet 14:3477-3492.
7. Gandhi S, et al. (2006) PINK1 protein in normal human brain and Parkinson's disease. Brain 129:1720-1731.
8. Plun-Favreau H, et al. (2007) The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. Nat Cell Biol 9:1243-1252.
9. Pridgeon JW, Olzmann JA, Chin LS, Li L (2007) PINK1 Protects against Oxidative Stress by Phosphorylating Mitochondrial Chaperone TRAP1. PLoS Biol 5:e172.
10. Exner N, et al. (2007) Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin. J Neurosci 27:12413-12418.
11. Rogaeva E, et al. (2004) Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease. Arch Neurol 61:1898-1904.
12. Rohe CF, et al. (2004) Homozygous PINK1 C-terminus mutation causing early-onset parkinsonism. Ann Neurol 56:427-431.
13. Nakajima A, Kataoka K, Hong M, Sakaguchi M, Huh NH (2003) BRPK, a novel protein kinase showing increased expression in mouse cancer cell lines with higher metastatic potential. Cancer Lett 201:195-201.
14. Unoki M, Nakamura Y (2001) Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway. Oncogene 20:4457-4465.
15. Clark IE, et al. (2006) Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441:1162-1166.
16. Park J, et al. (2006) Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441:1157-1161.
17. Kitada T, et al. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392:605-608.
18. Poole AC, et al. (2008) The PINK1/Parkin pathway regulates mitochondrial morphology. Proc Natl Acad Sci USA 105:1638-1643.
19. Darios F, et al. (2003) Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death. Hum Mol Genet 12:517-526.
20. Muqit MM, et al. (2006) Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress. J Neurochem 98:156-169.
21. Beilina A, et al. (2005) Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability. Proc Natl Acad Sci USA 102:5703-5708.
22. Haque ME, et al. (2008) Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP. Proc Natl Acad Sci USA 105:1716-1721.
23. Takatori S, Ito G, Iwatsubo T (2008) Cytoplasmic localization and proteasomal degradation of N-terminally cleaved form of PINK1. Neurosci Lett 430:13-17.
24. Weihofen A, Ostaszewski B, MinamiY, Selkoe DJ (2008) Pink1 Parkinson mutations, the Cdc37/Hsp90 chaperones and Parkin all influence the maturation or subcellular distribution of Pink1. Hum Mol Genet 17:602-616.
25. Cechetto JD, Gupta RS (2000) Immunoelectron microscopy provides evidence that tumor necrosis factor receptor-associated protein 1 (TRAP-1) is a mitochondrial protein which also localizes at specific extramitochondrial sites. Exp Cell Res 260:30-39.
26. Suzuki Y, et al. (2001) A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol Cell 8:613-621.
27. Gonzalez-Baro MR, Granger DA, ColemanRA(2001) Mitochondrial glycerol phosphate acyltransferase contains two transmembrane domains with the active site in the N-terminal domain facing the cytosol. J Biol Chem 276:43182-43188.
28. Donzeau M, et al. (2000) Tim23 links the inner and outer mitochondrial membranes. Cell 101:401-412.
29. Guo Y, et al. (2004) Tim50, a component of the mitochondrial translocator, regulates mitochondrial integrity and cell death. J Biol Chem 279:24813-24825.
30. Taymans JM, Van den HC, Baekelandt V (2006) Distribution of PINK1 and LRRK2 in rat and mouse brain. J Neurochem 98:951-961.
31. Blackinton JG, et al. (2007) Expression of PINK1 mRNA in human and rodent brain and in Parkinson's disease. Brain Res 1184:10-16.
32. Margineantu DH, Emerson CB, Diaz D, Hockenbery DM (2007) Hsp90 inhibition decreases mitochondrial protein turnover. PLoS ONE 2:e1066.
33. Bence NF, Sampat RM, Kopito RR (2001) Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292:1552-1555.
34. Pfanner N, GeisslerA(2001) Versatility of the mitochondrial protein import machinery. Nat Rev Mol Cell Biol 2:339-349.
35. Hackenbrock CR, Miller KJ (1975) The distribution of anionic sites on the surfaces of mitochondrial membranes. Visual probing with polycationic ferritin. J Cell Biol 65:615-630.
36. Kondo-Okamoto N, Shaw JM, Okamoto K (2003) Mmm1p spans both the outer and inner mitochondrial membranes and contains distinct domains for targeting and foci formation. J Biol Chem 278:48997-49005.
37. Burgess SM, Delannoy M, Jensen RE (1994) MMM1 encodes a mitochondrial outer membrane protein essential for establishing and maintaining the structure of yeast mitochondria. J Cell Biol 126:1375-1391.
38. Hobbs AE, Srinivasan M, McCaffery JM, Jensen RE (2001) Mmm1p, a mitochondrial outer membrane protein, is connected to mitochondrial DNA (mtDNA) nucleoids and required for mtDNA stability. J Cell Biol 152:401-410.
39. Kikuchi H, et al. (2006) Spinal cord endoplasmic reticulum stress associated with a microsomal accumulation of mutant superoxide dismutase-1 in an ALS model. Proc Natl Acad Sci USA 103:6025-6030.
40. Perier C, et al. (2007) Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson's disease. Proc Natl Acad Sci USA 104:8161-8166.